Classification and applicability of new beta-lactamase inhibitors
Revista Española de Quimioterapia · 2025-10-24 · 38 (S1) · 21-26
DOI: 10.37201/req/s01.03.2025 ↗Abstract
This non-exhaustive mini review describes the main characteristics of the new beta-lactamase inhibitors (enmetazobactam, avibactam, relebactam, durlobactam, zidebactam, nacubactam, vaborbactam, taniborbactam, and xeruborbactam), their spectrum of inhibition, their activity in combination with different beta-lactams, the main resistance mechanisms that can compromise their activity and the main applications of the different beta-lactam-beta-lactamase inhibitor combinations depending on the type of beta-lactamase/carbapenemase and the microorganism involved.
EUVIMED